Advent Life Sciences LLP 13D and 13G filings for Acutus Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 6:04 pm Unchanged | 2021-12-31 | 13G | Acutus Medical, Inc. AFIB | Advent Life Sciences LLP | 1,619,371 5.800% | 0 (Unchanged) | Filing |
| 2021-02-10 3:46 pm Purchase | 2020-12-31 | 13G | Acutus Medical, Inc. AFIB | Advent Life Sciences LLP | 1,619,371 5.800% | 1,619,371 (New Position) | Filing |